封面
市場調查報告書
商品編碼
1983227

酵素結合免疫吸附檢測法(ELISA) 市場:依方法、應用、技術及地區分類

Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, By Application, By Technology, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年,ELISA(酵素結合免疫吸附檢測法)市場規模將達到 24.566 億美元,到 2033 年將達到 34.76 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 5.1%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 24.566億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 5.10% 2033年市場規模預測: 34.76億美元

酵素連結免疫吸附試驗(ELISA)是免疫檢測。在生物醫學領域,ELISA 被用作一種診斷工具,透過檢測顏色變化來識別目標物質並測量其在測試樣本中的濃度。 ELISA 的常見診斷應用包括 HIV 感染(人類免疫力缺乏病毒)、懷孕檢測以及細胞激素和可溶性蛋白質的測定。此免疫檢測利用各種抗原-抗體組合,包括酵素標記的抗原或抗體,來測量酵素活性。根據抗原-抗體組合的不同, 檢測法可分為直接 ELISA、間接 ELISA、夾心 ELISA 和競爭性 ELISA。 HIV 等感染疾病的日益流行,以及人們對癌症和自體免疫疾病診斷意識的不斷提高,是推動 ELISA 需求成長的主要因素,旨在透過早期、準確的疾病診斷來減輕慢性疾病的負擔。

市場動態

預計在預測期內,市場新參與企業不斷推出新產品將推動全球ELISA市場成長。例如,2020年6月17日,體外診斷(IVD)產業的全球性公司J Mitra & Co Pvt Ltd在印度市場推出了一款COVID-19總抗體檢測ELISA檢測套組。本檢測套組能夠檢測所有COVID-19抗體,且不區分抗體類型,使其具有優異的性能。

本次調查的主要特點。

  • 本報告對全球 ELISA 市場進行了詳細分析,以 2021 年為基準年,給出了預測期(2022-2030 年)的市場規模和複合年成長率。
  • 本報告指出了各個細分市場的潛在商機,並說明了該市場中具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本報告根據以下參數介紹了全球 ELISA 市場中的主要企業概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 透過利用本報告中提出的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 本報告面向該產業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球 ELISA 市場分析中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 研究目標
  • 前提
  • 簡稱

第2章 市場範圍

  • 報告摘要
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機遇
  • 主要亮點
  • 市場趨勢
  • PEST分析
  • 政府和非政府組織計劃
  • 流行病學

第4章全球ELISA 市場:依方法分類,2026-2033 年

  • 概述
  • 直接ELISA
  • 間接ELISA
  • 夾心ELISA
  • 競爭性ELISA

第5章全球ELISA 市場:依應用領域分類,2026-2033 年

  • 概述
  • 疫苗研發
  • 免疫
  • 診斷
  • 毒性
  • 藥物監測和製藥業
  • 移植

第6章全球ELISA 市場:依技術分類,2026-2033 年

  • 化學冷光
  • 比色法
  • 螢光

第7章全球ELISA 市場:依地區分類,2026-2033 年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Bio-Rad Laboratories, Inc.
    • Enzo Life Sciences, Inc.
    • Thermo Fisher Scientific, Inc.
    • Biomerieux SA
    • Alpco
    • BioLegand, Inc.
    • R&D;Systems
    • Creative Diagnostics
    • Zeus Scientific, Inc.
    • Shenzhen YHLO Biotech Co., Ltd.

第9章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1505

Enzyme Linked Immunosorbent Assay Market is estimated to be valued at USD 2,456.60 Mn in 2026 and is expected to reach USD 3,476.00 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2,456.60 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 5.10% 2033 Value Projection: USD 3,476.00 Mn

Enzyme Linked Immunosorbent Assay (ELISA) is an immunoassay used to identify proteins, peptides, antibodies, and hormones. ELISA assay has application in biotechnology medicine, as a diagnostic tool, which detects color change to identify a target substance and measures its concentration in the test sample. The common diagnostic applications of ELISA are (Human Immunodeficiency Virus) HIV infection, pregnancy tests, and measurement of cytokines, soluble proteins, and others. Various antigen-antibody combinations are used in the immunoassay that include an enzyme-labeled antigen or antibody and enzyme activity is measured. On the basis of antigen-antibody combination, the assay is segmented into direct ELISA, indirect ELISA, sandwich ELISA, and competitive ELISA. Increasing prevalence of infectious disease such as HIV and increasing awareness regarding diagnosis of cancer and autoimmune diseases are major factors propelling demand for ELISA to reduce the burden of chronic diseases with early and accurate disease diagnosis.

Market Dynamics

Increasing product launches by market players is expected to of drive growth of the global Enzyme Linked Immunosorbent Assay (ELISA) Market over the forecast period. For instance, On June 17, 2020, J Mitra & Co Pvt Ltd, a global company in the In-Vitro Diagnostics (IVD) industry had launched COVID-19 total antibody detection Elisa test kit in the Indian market. It is a Double-Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total antibody (IgM, IgG, IgA) detection assay. All the COVID-19 antibodies are detected without differentiation in antibodies, and this is the reason contributing to the superior performance of this test.

Key features of the study

  • This report provides an in-depth analysis of the global Enzyme Linked Immunosorbent Assay (ELISA) Market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global Enzyme Linked Immunosorbent Assay (ELISA) Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., R&D Systems, Creative Diagnostics, Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global Enzyme Linked Immunosorbent Assay (ELISA) Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Enzyme Linked Immunosorbent Assay (ELISA) Market

Market Segmentation

  • By Method
    • Direct ELISA
    • Indirect ELISA
    • Sandwich ELISA
    • Competitive ELISA
  • By Application
    • Vaccine Development
    • Immunology
    • Diagnostics
    • Toxicology
    • Drug Monitoring & Pharmaceutical Industry
    • Transplantation
  • By Technology
    • Chemiluminescent
    • Colorimetric
    • Fluorescent
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Bio-Rad Laboratories, Inc.
    • Enzo Life Sciences, Inc.
    • Thermo Fisher Scientific, Inc.
    • Biomerieux S.A.
    • Alpco, BioLegand, Inc.
    • R&D Systems
    • Creative Diagnostics
    • Zeus Scientific, Inc.
    • Shenzhen YHL.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Method
    • Market Snapshot, By Application
    • Market Snapshot, By Technology
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • Government & Non-Government Initiatives
  • Epidemiology

4. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Method, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Direct ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Indirect ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Sandwich ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Competitive ELISA
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Application, 2026 - 2033, (USD Mn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Vaccine Development
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Immunology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Diagnostics
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Toxicology
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Drug Monitoring & Pharmaceutical Industry
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
  • Transplantation
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Technology, 2026 - 2033, (USD Mn)

    • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 20230
    • Segment Trends
  • Chemiluminescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Colorimetric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
  • Fluorescent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Enzyme Linked Immunosorbent Assay (ELISA) Market, By Region, 2026 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • UK
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Method, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profiles
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Enzo Life Sciences, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biomerieux S.A.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Alpco
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • BioLegand, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • R&D Systems
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Creative Diagnostics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Zeus Scientific, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Shenzhen YHLO Biotech Co., Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Section

  • Research Methodology
  • About Us